Pharma Community Faces Unique Hurdles to Sustainability

Despite sustainability becoming increasingly important to pharmaceutical consumers, the barriers to making packaging changes in the pharmaceutical industry are high, says a new study from PMMI Business Intelligence.

Getty Images 1342104804

According to the new white paper, β€œ Pharmaceutical Manufacturing, Trends Shaping The Future,” any new packaging format must be validated and certified to meet industry regulations. For instance, any new format must also contain the appropriate closures, seals, and child-proof features required for the particular product.

β€œWe have had some machine issues when using thinner grade materials, and have returned to the original thickness for better quality.”

--Director of Engineering, CMO, OTC

Listen to article   

Listen to this podcast on sustainability in healthcare packaging.

The material must also have sufficient barrier properties to prevent both intrusion from outside environmental factors, as well as internal leeching into or from the product it contains. Material changes can also create additional production challenges, such as second-use materials generating dust during processing, a contaminant that is incompatible with the sanitary environment required for pharmaceutical production.

β€œWhen we make dimensional changes to our package, it typically requires a new labeler and revalidating the new format.”

--Director of Engineering, CMO, OTC

These extra considerations result in the pharmaceutical industry being slower to take up sustainable packaging alternatives, as they must go through more rigorous testing and validation before being implemented.

Watch video   Watch this video on Amcor's fully recyclable PVC-free blister pack.

Fill out the form below to request more information about Pharma Community Faces Unique Hurdles to Sustainability